Disclosures for "Clinical and Mechanistic Insights into Non-ICANS Neurotoxicity Following BCMA CAR T-cell Therapy"
-
The institution of Dr. Muller-Jensen has received research support from Else Kröner-Fresenius-Stiftung (EKFS). Dr. Muller-Jensen has received research support from Deutsche Forschungsgemeinschaft (DFG). Dr. Muller-Jensen has received personal compensation in the range of $0-$499 for serving as a Compensation for invited lecture with AAN.
-
Dr. Kwek has nothing to disclose.
-
Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Legend. The institution of Dr. Kumar has received research support from Astrazeneca. The institution of Dr. Kumar has received research support from Bristol Myers Squibb. The institution of Dr. Kumar has received research support from Celgene.
-
Jiuling Yang has nothing to disclose.
-
Mr. He has nothing to disclose.
-
Mrs. Fouassier has nothing to disclose.
-
Ms. Hughes has nothing to disclose.
-
Nothing to Disclose
-
Dr. Dhawan has nothing to disclose.
-
Dr. Lipof has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kite/arcellx. Dr. Lipof has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca.
-
Dr. Pan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Pan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Pan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron.
-
Dr. Chung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson Innovative Medicine. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers-Squibb. The institution of Dr. Chung has received research support from Abbvie. The institution of Dr. Chung has received research support from Bristol Myers Squibb. The institution of Dr. Chung has received research support from Caelum Biosciences. The institution of Dr. Chung has received research support from CARsgen Therapeutics. The institution of Dr. Chung has received research support from Johnson and Johnson Innovative Medicine . The institution of Dr. Chung has received research support from K36 Therapeutics .
-
Miss Hill has nothing to disclose.
-
Mr. Hernandez has nothing to disclose.
-
Dr. Patino-Escobar has nothing to disclose.
-
Dr. Wiita has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Wiita has or had stock in Seen Therapeutics.
-
Dr. Sayre has nothing to disclose.
-
Dr. Wolf has nothing to disclose.
-
Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from NIH. The institution of Dr. Green has received research support from NIH / NINDS. The institution of Dr. Green has received research support from NIH / NINDS. Dr. Green has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Martin has received personal compensation for serving as an employee of GSK. Dr. Martin has received personal compensation for serving as an employee of Lilly. Dr. Martin has received personal compensation for serving as an employee of Pfizer. Dr. Martin has received personal compensation for serving as an employee of AstraZeneca. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pfizer. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for astrazeneca. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for gsk. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for pfizer. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Martin has received research support from sanofi. Dr. Martin has received research support from janssen. Dr. Martin has received research support from BMS.
-
Dr. arora has nothing to disclose.
-
Dr. Chari has received personal compensation for serving as an employee of UCSF. Dr. Chari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for abbvie. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for adaptive. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Antegene. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Forus. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Forus. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Chari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karyopharm. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Chari has received research support from Janssen.
-
Dr. Oh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revelation Partners. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tatum Biosciences. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartography Biosciences. The institution of Dr. Oh has received research support from Merck Sharp Dohme. The institution of Dr. Oh has received research support from PACT Pharma. The institution of Dr. Oh has received research support from Poseida Therapeutics. The institution of Dr. Oh has received research support from TCR2 Therapeutics. The institution of Dr. Oh has received research support from Roche/Genentech. The institution of Dr. Oh has received research support from Nutcracker Therapeutics. The institution of Dr. Oh has received research support from Amgen. The institution of Dr. Oh has received research support from Allogene. The institution of Dr. Oh has received research support from Clasp Therapeutics. The institution of Dr. Oh has received research support from Janux Therapeutics. Dr. Oh has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend . Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
-
The institution of Dr. Abdelhak has received research support from German Multiple Sclerosis Society.